FUBT
First United Bank & Trust Portfolio holdings
AUM $287M
1-Year Return
14.35%
This Quarter Return
-2.68%
1 Year Return
+14.35%
3 Year Return
+60.38%
5 Year Return
+104.97%
10 Year Return
+221.8%
AUM
$268M
AUM Growth
-$7.67M
(-2.8%)
Cap. Flow
+$1.47M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
421
New
44
Increased
57
Reduced
152
Closed
19
Top Buys
| 1 |
Arista Networks
ANET
|
+$3.37M |
| 2 |
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
|
+$1.34M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$1.2M |
| 4 |
Fidelity Total Bond ETF
FBND
|
+$954K |
| 5 |
iShares Select Dividend ETF
DVY
|
+$744K |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.29M |
| 2 |
Fidelity Nasdaq Composite Index ETF
ONEQ
|
+$999K |
| 3 |
Johnson & Johnson
JNJ
|
+$726K |
| 4 |
FlexShares STOXX US ESG Select Index Fund
ESG
|
+$697K |
| 5 |
Vanguard Growth ETF
VUG
|
+$635K |
Sector Composition
| 1 | Technology | 12.83% |
| 2 | Financials | 8.1% |
| 3 | Healthcare | 5.6% |
| 4 | Consumer Discretionary | 4.57% |
| 5 | Industrials | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Labcorp
LH
$22.9B
| $4.66K | ﹤0.01% |
20
| – | – |
|
352
Vermilion Energy
VET
$1.2B
| $4.55K | ﹤0.01% |
+562
| New | +$4.55K |
|
353
Progressive
PGR
$143B
| $4.53K | ﹤0.01% |
+16
| New | +$4.53K |
|
354
Centene
CNC
$15.7B
| $4.25K | ﹤0.01% |
70
| – | – |
|
355
Liberty All-Star Equity Fund
USA
$1.91B
| $4.11K | ﹤0.01% |
627
| – | – |
|
356
PACCAR
PCAR
$53B
| $4.09K | ﹤0.01% |
+42
| New | +$4.09K |
|
357
Knight Transportation
KNX
$6.77B
| $4.05K | ﹤0.01% |
93
| – | – |
|
358
DNP Select Income Fund
DNP
$3.7B
| $3.97K | ﹤0.01% |
401
-420
| -51% | -$4.15K |
|
359
First Trust Preferred Securities and Income ETF
FPE
$6.22B
| $3.87K | ﹤0.01% |
220
| – | – |
|
360
Linde
LIN
$225B
| $3.73K | ﹤0.01% |
8
| – | – |
|
361
Enterprise Products Partners
EPD
$69.4B
| $3.41K | ﹤0.01% |
100
| – | – |
|
362
Boeing
BA
$162B
| $3.41K | ﹤0.01% |
20
| – | – |
|
363
CRISPR Therapeutics
CRSP
$5.37B
| $3.4K | ﹤0.01% |
100
| – | – |
|
364
Iovance Biotherapeutics
IOVA
$803M
| $3.33K | ﹤0.01% |
1,000
| – | – |
|
|
OKLO
365
Oklo
OKLO
$14.1B
| $3.25K | ﹤0.01% |
150
+75
| +100% | +$1.62K |
|
366
Rivian
RIVN
$17.1B
| $3.11K | ﹤0.01% |
250
| – | – |
|
367
W.R. Berkley
WRB
$27.7B
| $3.06K | ﹤0.01% |
+43
| New | +$3.06K |
|
368
Kraft Heinz
KHC
$30.5B
| $2.98K | ﹤0.01% |
98
| – | – |
|
369
HEICO Class A
HEI.A
$34.9B
| $2.95K | ﹤0.01% |
+14
| New | +$2.95K |
|
370
Alibaba
BABA
$396B
| $2.91K | ﹤0.01% |
+22
| New | +$2.91K |
|
371
TransDigm Group
TDG
$71.9B
| $2.77K | ﹤0.01% |
+2
| New | +$2.77K |
|
372
Biogen
BIIB
$21.2B
| $2.74K | ﹤0.01% |
20
| – | – |
|
373
Interactive Brokers
IBKR
$27.8B
| $2.65K | ﹤0.01% |
+64
| New | +$2.65K |
|
374
LPL Financial
LPLA
$26.9B
| $2.62K | ﹤0.01% |
+8
| New | +$2.62K |
|
375
Genworth Financial
GNW
$3.52B
| $2.59K | ﹤0.01% |
365
| – | – |
|